Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.19 | 0.004 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |